TickerFactsScreenerDevelopers

Skye Bioscience, Inc. (SKYE) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: $25.9K2012: -$61.8K2013: -$182.2K2014: -$453.5K2015: -$892.2K2016: -$2.91M2017: -$3.57M2018: -$15.56M2019: $548.1K2020: $450.8K2021: $5.86M2022: -$3.01M2023: -$2.13M2024: $68.15M2025: $20.02M$20.02M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$20.02M-70.6%
2024$68.15M+3296.9%
2023-$2.13M+29.1%
2022-$3.01M-151.3%
2021$5.86M+1200.9%
2020$450.8K-17.7%
2019$548.1K+103.5%
2018-$15.56M-336.0%
2017-$3.57M-22.5%
2016-$2.91M-226.6%
2015-$892.2K-96.7%
2014-$453.5K-149.0%
2013-$182.2K-195.0%
2012-$61.8K-338.0%
2011$25.9K—